Zeon Corporation Acquires Aurora Microplates
February 3, 2022
Zeon Corporation has reached an agreement to acquire Aurora Microplates, a manufacturer of high-performance microplates used in drug discovery and diagnostic research. The deal, announced in Tokyo, will allow Zeon to enter the microplate market and expand into research and diagnostics by integrating a long-term supplier into its product portfolio; the transaction is expected to close by February 28, 2022.
- Buyers
- Zeon Corporation
- Targets
- Aurora Microplates
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Zeon Corporation Acquires Edge Precision Manufacturing, Inc.
December 28, 2022
Medical Devices
Zeon Corporation, through its U.S. subsidiary Zeon Specialty Materials Inc., purchased 100% of Edge Precision Manufacturing, Inc., a Massachusetts-based manufacturer of micro‑featured thermoplastic disposables, on December 28, 2022. The acquisition strengthens Zeon's cyclo olefin polymer (COP) offering for microfluidic and diagnostic devices by combining Zeon's materials with Edge's precision compression‑molding capabilities and customer network.
-
Quanterix Completes Acquisition of Akoya Biosciences
July 8, 2025
Healthcare Services
Quanterix completed its previously announced acquisition of Akoya Biosciences under the amended merger agreement, issuing about 7.8 million shares and paying about $20 million in cash in the aggregate to Akoya holders. The companies positioned the deal as creating an integrated platform for measuring biomarkers across the blood and tissue continuum and expanding addressable markets.
-
Nautic Partners Acquires Aurora Plastics
August 11, 2021
Manufacturing
Nautic Partners has completed the acquisition of Aurora Plastics, a Streetsboro, Ohio-based producer of PVC and custom polymer compounds, in partnership with Aurora management. The seller parties were Wind Point Partners and Ontario Teachers' Pension Plan Board; financing for the deal was led by Antares Capital and Carlyle Global Credit, and Nautic says it will support Aurora's growth and pursue acquisitions in the fragmented specialty compounds market.
-
AstraZeneca Acquires Fusion Pharmaceuticals
March 19, 2024
Biotechnology
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage company developing next-generation actinium-based radioconjugates, for $21.00 per share in cash plus a non-transferable contingent value right that could bring the total to approximately $2.4 billion. The acquisition adds Fusion's pipeline (including FPI-2265 for mCRPC), R&D and manufacturing capabilities in radioconjugates and strengthens AstraZeneca's oncology portfolio and presence in Canada.
-
Asahi Kasei Medical to Acquire Bionova Scientific
April 14, 2022
Healthcare Services
Asahi Kasei Medical, through a U.S. subsidiary, has agreed to wholly acquire Bionova Scientific, LLC, a U.S.-based biopharmaceutical CDMO providing contract process development and GMP-compliant contract manufacturing services. The acquisition will add CDMO capabilities to Asahi Kasei Medical’s existing bioprocess business and broaden know-how-driven services for next-generation antibody drugs.
-
Excelitas Technologies Acquires Phoseon Technology
February 15, 2023
Manufacturing
Excelitas Technologies Corp. completed the acquisition of Phoseon Technology, Inc. on February 15, 2023, adding Phoseon's LED-based UV curing and scientific illumination capabilities to its commercial business unit. Phoseon will continue to operate from its Hillsboro, Oregon headquarters and the deal expands Excelitas' product portfolio and R&D cooperation in UV LED solutions across industrial, medical device, electronics and life-sciences end markets.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.